바이오테크놀러지 수탁제조 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 서비스별, 유형별, 사업 규모별, 치료 영역별, 지역별, 경쟁별 세분화(2020-2030년)
Biotechnology Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Type, By Scale of Operation, By Therapeutic Area, By Region and Competition, 2020-2030F
상품코드:1886287
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 바이오테크놀러지 수탁제조 시장은 2024년에 221억 5,000만 달러로 평가되며, 2030년까지 CAGR 7.48%로 성장하며, 341억 5,000만 달러에 달할 것으로 예측됩니다. 바이오 수탁제조은 의약품 개발 및 제조에 관한 전문 서비스를 제3의 기관에 위탁하는 것으로, 이를 통해 바이오 제약기업은 연구개발 등 핵심 업무에 집중할 수 있습니다. 이러한 서비스에는 일반적으로 세포주 개발, 공정 최적화, 제조, 제형화, 충전 및 마무리 공정, 포장 등이 포함됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
221억 5,000만 달러
시장 규모 : 2030년
341억 5,000만 달러
CAGR : 2025-2030년
7.48%
가장 빠르게 성장하는 부문
제조업
최대 시장
북미
주요 시장 성장 촉진요인
세계 생명공학 수탁제조 시장은 생물제제 및 첨단 치료법에 대한 수요 증가로 인해 크게 형성되고 있습니다. 바이오제약 기업은 단클론 항체, 세포 및 유전자 치료제를 포함한 복잡한 생물학적 제품에 대한 관심이 높아짐에 따라 위탁개발생산기관(CDMO)의 전문적 지식과 첨단 제조 역량을 요구하고 있습니다.
주요 시장 과제
지적재산권(IP)의 복잡한 상황은 전 세계 생명공학 수탁제조 시장의 성장에 큰 도전이 되고 있습니다. 제3자 기관과 계약을 맺는 바이오제약 기업은 독점 정보의 보호와 공유에 대해 세심한 주의를 기울여야 하며, 이는 종종 복잡한 계약과 막대한 법적 비용을 수반하는 경우가 많습니다.
주요 시장 동향
중요한 동향으로는 세계 공급망의 탄력성 강화와 분산형 제조로의 전환을 꼽을 수 있습니다. 바이오제약 기업은 지정학적 불안정성 및 물류 관련 리스크를 줄이기 위해 보다 지역밀착형 및 다각화된 생산 네트워크에 대한 투자를 적극적으로 추진하고 있습니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 바이오테크놀러지 수탁제조 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
서비스별(제조, 제제·Fill-Finish, 포장·표시, 기타 서비스)
유형별(생물학적 원료의약품 제조, 생물학적 의약품 제제 제조)
사업 규모별(상업 생산, 임상 생산)
치료 영역별(자가면역질환, 심혈관 질환, 대사성 질환, 감염증, 신경학, 기타 치료 영역)
지역별
기업별(2024)
시장 맵
제6장 북미의 바이오테크놀러지 수탁제조 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 바이오테크놀러지 수탁제조 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 바이오테크놀러지 수탁제조 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 바이오테크놀러지 수탁제조 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 바이오테크놀러지 수탁제조 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 바이오테크놀러지 수탁제조 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Lonza Group Ltd.
Thermo Fisher Scientific, Inc.
Wuxi Biologics Co., Ltd.
Catalent, Inc.
Samsung Biologics Co., Ltd.
Boehringer Ingelheim International GmbH
Fujifilm Holdings Corporation
Abbvie Inc.
Eurofins Scientific SE
Genscript Biotech Corporation
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Biotechnology Contract Manufacturing Market, valued at USD 22.15 Billion in 2024, is projected to experience a CAGR of 7.48% to reach USD 34.15 Billion by 2030. Biotechnology contract manufacturing involves the outsourcing of specialized services for drug development and manufacturing to third-party organizations, enabling biopharmaceutical companies to concentrate on core competencies such as research and development. These services typically encompass cell line development, process optimization, manufacturing, formulation, fill-finish operations, and packaging.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 22.15 Billion
Market Size 2030
USD 34.15 Billion
CAGR 2025-2030
7.48%
Fastest Growing Segment
Manufacturing
Largest Market
North America
Key Market Drivers
The global biotechnology contract manufacturing market is significantly shaped by the escalating demand for biologics and advanced therapies. This growing focus on complex biological products, including monoclonal antibodies and cell and gene therapies, drives biopharmaceutical companies to seek specialized expertise and advanced manufacturing capabilities from contract development and manufacturing organizations.
Key Market Challenges
The intricate landscape of intellectual property (IP) rights presents a significant challenge to the growth of the Global Biotechnology Contract Manufacturing Market. Biopharmaceutical companies engaging third-party organizations must meticulously navigate the protection and sharing of proprietary information, which often involves complex agreements and substantial legal costs. This complexity introduces hesitancy and can delay outsourcing decisions for critical drug development and manufacturing projects, directly impacting market expansion.
Key Market Trends
A significant trend involves the strengthening of global supply chain resilience and the move towards distributed manufacturing. Biopharmaceutical companies are actively seeking to mitigate risks associated with geopolitical instabilities and logistical challenges, driving investments in more localized and diversified production networks. According to Cytiva's 2023 Global Biopharma Resilience Index, overall supply chain resilience improved slightly from 6.72 in 2021 to 6.84 in 2023, indicating ongoing industry efforts to fortify manufacturing capabilities.
Key Market Players
Lonza Group Ltd.
Thermo Fisher Scientific, Inc.
Wuxi Biologics Co., Ltd.
Catalent, Inc.
Samsung Biologics Co., Ltd.
Boehringer Ingelheim International GmbH
Fujifilm Holdings Corporation
Abbvie Inc.
Eurofins Scientific SE
Genscript Biotech Corporation
Report Scope:
In this report, the Global Biotechnology Contract Manufacturing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Biotechnology Contract Manufacturing Market, By Service:
Manufacturing
Formulation and Fill-Finish
Packaging and Labeling
Other services
Biotechnology Contract Manufacturing Market, By Type:
Biologic Drug Substance Manufacturing
Biologic Drug ProductManufacturing
Biotechnology Contract Manufacturing Market, By Scale of Operation:
Commercial Operations
Clinical Operations
Biotechnology Contract Manufacturing Market, By Therapeutic Area:
Autoimmune Diseases
Cardiovascular Diseases
Metabolic Diseases
Infectious Diseases
Neurology
Other Therapeutic Areas
Biotechnology Contract Manufacturing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Biotechnology Contract Manufacturing Market.
Available Customizations:
Global Biotechnology Contract Manufacturing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Biotechnology Contract Manufacturing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Other services)
5.2.2. By Type (Biologic Drug Substance Manufacturing, Biologic Drug ProductManufacturing)
5.2.3. By Scale of Operation (Commercial Operations, Clinical Operations)
5.2.4. By Therapeutic Area (Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Other Therapeutic Areas)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Biotechnology Contract Manufacturing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service
6.2.2. By Type
6.2.3. By Scale of Operation
6.2.4. By Therapeutic Area
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Biotechnology Contract Manufacturing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Type
6.3.1.2.3. By Scale of Operation
6.3.1.2.4. By Therapeutic Area
6.3.2. Canada Biotechnology Contract Manufacturing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Type
6.3.2.2.3. By Scale of Operation
6.3.2.2.4. By Therapeutic Area
6.3.3. Mexico Biotechnology Contract Manufacturing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Type
6.3.3.2.3. By Scale of Operation
6.3.3.2.4. By Therapeutic Area
7. Europe Biotechnology Contract Manufacturing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Type
7.2.3. By Scale of Operation
7.2.4. By Therapeutic Area
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Biotechnology Contract Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Type
7.3.1.2.3. By Scale of Operation
7.3.1.2.4. By Therapeutic Area
7.3.2. France Biotechnology Contract Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Type
7.3.2.2.3. By Scale of Operation
7.3.2.2.4. By Therapeutic Area
7.3.3. United Kingdom Biotechnology Contract Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Type
7.3.3.2.3. By Scale of Operation
7.3.3.2.4. By Therapeutic Area
7.3.4. Italy Biotechnology Contract Manufacturing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Type
7.3.4.2.3. By Scale of Operation
7.3.4.2.4. By Therapeutic Area
7.3.5. Spain Biotechnology Contract Manufacturing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Type
7.3.5.2.3. By Scale of Operation
7.3.5.2.4. By Therapeutic Area
8. Asia Pacific Biotechnology Contract Manufacturing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Type
8.2.3. By Scale of Operation
8.2.4. By Therapeutic Area
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Biotechnology Contract Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Type
8.3.1.2.3. By Scale of Operation
8.3.1.2.4. By Therapeutic Area
8.3.2. India Biotechnology Contract Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Type
8.3.2.2.3. By Scale of Operation
8.3.2.2.4. By Therapeutic Area
8.3.3. Japan Biotechnology Contract Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Type
8.3.3.2.3. By Scale of Operation
8.3.3.2.4. By Therapeutic Area
8.3.4. South Korea Biotechnology Contract Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Type
8.3.4.2.3. By Scale of Operation
8.3.4.2.4. By Therapeutic Area
8.3.5. Australia Biotechnology Contract Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Type
8.3.5.2.3. By Scale of Operation
8.3.5.2.4. By Therapeutic Area
9. Middle East & Africa Biotechnology Contract Manufacturing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Type
9.2.3. By Scale of Operation
9.2.4. By Therapeutic Area
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Biotechnology Contract Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Type
9.3.1.2.3. By Scale of Operation
9.3.1.2.4. By Therapeutic Area
9.3.2. UAE Biotechnology Contract Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Type
9.3.2.2.3. By Scale of Operation
9.3.2.2.4. By Therapeutic Area
9.3.3. South Africa Biotechnology Contract Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Type
9.3.3.2.3. By Scale of Operation
9.3.3.2.4. By Therapeutic Area
10. South America Biotechnology Contract Manufacturing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Type
10.2.3. By Scale of Operation
10.2.4. By Therapeutic Area
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Biotechnology Contract Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Type
10.3.1.2.3. By Scale of Operation
10.3.1.2.4. By Therapeutic Area
10.3.2. Colombia Biotechnology Contract Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Type
10.3.2.2.3. By Scale of Operation
10.3.2.2.4. By Therapeutic Area
10.3.3. Argentina Biotechnology Contract Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Type
10.3.3.2.3. By Scale of Operation
10.3.3.2.4. By Therapeutic Area
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Biotechnology Contract Manufacturing Market: SWOT Analysis
